Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 6/2022

14.06.2022 | ESCP Best Practice

The first nationwide implementation of pharmaceutical care practices through a continuing professional development approach for community pharmacists

verfasst von: Sule Apikoglu, Aysu Selcuk, Vildan Ozcan, Ecehan Balta, Meltem Turker, Ozge Durak Albayrak, Arijana Mestrovic, Michael Rouse, Arman Uney

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Noncommunicable diseases account for the majority of all deaths and impose a high socioeconomic burden, causing disability and premature deaths. Pharmacists can contribute to the prevention and management of these diseases through the provision of pharmaceutical care services.

Aim

The aim of this study was to implement a nationwide practice developed by the Turkish Pharmacists’ Association aiming to realize pharmaceutical care provision of standard quality to patients with asthma, chronic obstructive pulmonary disease, diabetes and hypertension at community pharmacies through a continuing professional development approach.

Setting

Community pharmacies in Turkey.

Development

A project with the involvement of all community pharmacists who were willing to participate was developed. After piloting, the ‘project’ turned into a ‘practice’ with a focus on asthma, chronic obstructive pulmonary disease, diabetes and hypertension management.

Implementation

The training process occurred as a peer-training activity. Consultants and academic staff trained the trainer pharmacists during a 3-day course. Community pharmacists (n = 6161) received training regarding pharmaceutical care, asthma, chronic obstructive pulmonary disease, diabetes and hypertension from their peer trainers (n = 341) and began to practice pharmaceutical care and follow-up of patients’ outcomes on a regular basis.

Evaluation

Among all community pharmacists in Turkey (n = 26,177), 24% attended training. Among these pharmacists, 21% started to implement practice. With community pharmacists’ contribution to patient care, significant improvements in the majority of the outcome parameters regarding asthma, chronic obstructive pulmonary disease, diabetes and hypertension management were noted.

Conclusion

This first nationwide practice showed us that community pharmacists can help improve the health outcomes of patients with asthma, chronic obstructive pulmonary disease, diabetes and hypertension through the provision of pharmaceutical care services.
Literatur
6.
Zurück zum Zitat Committee of Ministers, Council of Europe. CM/Res(2020). Resolution on the Implementation of Pharmaceutical Care for the Benefit of Patients and Health Services. 2020. Available online: https://rm.coe.int/09000016809cdf26. Accessed date: 08.12.2020. Committee of Ministers, Council of Europe. CM/Res(2020). Resolution on the Implementation of Pharmaceutical Care for the Benefit of Patients and Health Services. 2020. Available online: https://​rm.​coe.​int/​09000016809cdf26​. Accessed date: 08.12.2020.
8.
Zurück zum Zitat Apikoglu-Rabus S, Yesilyaprak G, Izzettin FV. Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease. Respir Med. 2016;120:109–15.CrossRefPubMed Apikoglu-Rabus S, Yesilyaprak G, Izzettin FV. Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease. Respir Med. 2016;120:109–15.CrossRefPubMed
9.
Zurück zum Zitat Selcuk A, Sancar M, Okuyan B, et al. The potential role of clinical pharmacists in elderly patients during hospital admission. Pharmazie. 2015;70:559–62.PubMed Selcuk A, Sancar M, Okuyan B, et al. The potential role of clinical pharmacists in elderly patients during hospital admission. Pharmazie. 2015;70:559–62.PubMed
10.
Zurück zum Zitat Kara E, İnkaya A, Aydın Haklı D, et al. Polypharmacy and drug-related problems among people living with HIV/AIDS: a single-center experience. Turk J Med Sci. 2019;49:222–9.PubMedPubMedCentral Kara E, İnkaya A, Aydın Haklı D, et al. Polypharmacy and drug-related problems among people living with HIV/AIDS: a single-center experience. Turk J Med Sci. 2019;49:222–9.PubMedPubMedCentral
11.
Zurück zum Zitat Tezcan S, İzzettin FV, Sancar M, et al. Role of clinical oncology pharmacist in determination of pharmaceutical care needs in patients with colorectal cancer. Eur J Hosp Pharm. 2018;25:17–20.CrossRef Tezcan S, İzzettin FV, Sancar M, et al. Role of clinical oncology pharmacist in determination of pharmaceutical care needs in patients with colorectal cancer. Eur J Hosp Pharm. 2018;25:17–20.CrossRef
16.
Zurück zum Zitat Koschack J, Marx G, Schnakenberg J. et.al. Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties. J Clin Epidemiol. 2010;63:299–306.CrossRefPubMed Koschack J, Marx G, Schnakenberg J. et.al. Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties. J Clin Epidemiol. 2010;63:299–306.CrossRefPubMed
17.
Zurück zum Zitat Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.CrossRefPubMed Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.CrossRefPubMed
21.
Zurück zum Zitat Al-Babtain B, Cheema E, Hadi MA. Impact of community-pharmacist-led medication review programmes on patient outcomes: A systematic review and meta-analysis of randomised controlled trials. Res Social Adm Pharm. 2021;S1551-7411(21)00163-7. Al-Babtain B, Cheema E, Hadi MA. Impact of community-pharmacist-led medication review programmes on patient outcomes: A systematic review and meta-analysis of randomised controlled trials. Res Social Adm Pharm. 2021;S1551-7411(21)00163-7.
22.
Zurück zum Zitat Cheema E, Sutcliffe P, Singer DR. The impact of interventions by pharmacists in community pharmacies on control of hypertension: A systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2014;78(6):1238–47.CrossRefPubMedPubMedCentral Cheema E, Sutcliffe P, Singer DR. The impact of interventions by pharmacists in community pharmacies on control of hypertension: A systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2014;78(6):1238–47.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Deters MA, Laven A, Castejon A, et al. Effective interventions for diabetes patients by community pharmacists: A meta-analysis of pharmaceutical care components. Ann Pharmacother. 2018;52(2):198–211.CrossRefPubMed Deters MA, Laven A, Castejon A, et al. Effective interventions for diabetes patients by community pharmacists: A meta-analysis of pharmaceutical care components. Ann Pharmacother. 2018;52(2):198–211.CrossRefPubMed
24.
Zurück zum Zitat Fathima M, Naik-Panvelkar P, Saini B, et al. The role of community pharmacists in screening and subsequent management of chronic respiratory diseases: A systematic review. Pharm Pract (Granada). 2013;11(4):228–45.CrossRefPubMed Fathima M, Naik-Panvelkar P, Saini B, et al. The role of community pharmacists in screening and subsequent management of chronic respiratory diseases: A systematic review. Pharm Pract (Granada). 2013;11(4):228–45.CrossRefPubMed
25.
Zurück zum Zitat Armour CL, Bosnic-Anticevich S, Brillant M. et.al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax. 2007;62(6):496–502.CrossRefPubMedPubMedCentral Armour CL, Bosnic-Anticevich S, Brillant M. et.al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax. 2007;62(6):496–502.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Mahdavi H, Esmaily H. Impact of educational intervention by community pharmacists on asthma clinical outcomes, quality of life and medication adherence: A systematic review and meta-analysis. J Clin Pharm Ther. 2021. Mahdavi H, Esmaily H. Impact of educational intervention by community pharmacists on asthma clinical outcomes, quality of life and medication adherence: A systematic review and meta-analysis. J Clin Pharm Ther. 2021.
28.
Zurück zum Zitat Manfrin A, Tinelli M, Thomas T, et al. A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients. BMC Health Serv Res. 2017;17(1):300.CrossRefPubMedPubMedCentral Manfrin A, Tinelli M, Thomas T, et al. A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients. BMC Health Serv Res. 2017;17(1):300.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Rodrigues AT, Romano S, Romão M, et al. Effectiveness of a pharmacist-led intervention on inhalation technique for asthma and COPD patients: The INSPIRA pilot cluster-randomized controlled trial. Respir Med. 2021;185:1–8.CrossRef Rodrigues AT, Romano S, Romão M, et al. Effectiveness of a pharmacist-led intervention on inhalation technique for asthma and COPD patients: The INSPIRA pilot cluster-randomized controlled trial. Respir Med. 2021;185:1–8.CrossRef
30.
Zurück zum Zitat Tommelein E, Mehuys E, Van Hees T, et al. Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): A randomized controlled trial. Br J Clin Pharmacol. 2014;77(5):756–66.CrossRefPubMedPubMedCentral Tommelein E, Mehuys E, Van Hees T, et al. Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): A randomized controlled trial. Br J Clin Pharmacol. 2014;77(5):756–66.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Hämmerlein A, Müller U, Schulz M. Pharmacist-led intervention study to improve inhalation technique in asthma and COPD patients. J Eval Clin Pract. 2011;17(1):61–70.CrossRefPubMed Hämmerlein A, Müller U, Schulz M. Pharmacist-led intervention study to improve inhalation technique in asthma and COPD patients. J Eval Clin Pract. 2011;17(1):61–70.CrossRefPubMed
32.
Zurück zum Zitat Mehuys E, Van Bortel L, De Bolle L, et al. Effectiveness of a community pharmacist intervention in diabetes care: A randomized controlled trial. J Clin Pharm Ther. 2011;36(5):602–13.CrossRefPubMed Mehuys E, Van Bortel L, De Bolle L, et al. Effectiveness of a community pharmacist intervention in diabetes care: A randomized controlled trial. J Clin Pharm Ther. 2011;36(5):602–13.CrossRefPubMed
33.
Zurück zum Zitat Ali M, Schifano F, Robinson P, et al. Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study. Diabet Med. 2012;29(9):326–33.CrossRef Ali M, Schifano F, Robinson P, et al. Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study. Diabet Med. 2012;29(9):326–33.CrossRef
34.
Zurück zum Zitat Fornos JA, Andrés NF, Andrés JC, et al. A Pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain. Pharm World Sci. 2006;28:65–72.CrossRefPubMed Fornos JA, Andrés NF, Andrés JC, et al. A Pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain. Pharm World Sci. 2006;28:65–72.CrossRefPubMed
35.
Zurück zum Zitat Stewart K, George J, Mc Namara KP, et al. A multifaceted pharmacist intervention to improve antihypertensive adherence: A cluster-randomized, controlled trial (HAPPy trial). J Clin Pharm Ther. 2014;39(5):527–34.CrossRefPubMed Stewart K, George J, Mc Namara KP, et al. A multifaceted pharmacist intervention to improve antihypertensive adherence: A cluster-randomized, controlled trial (HAPPy trial). J Clin Pharm Ther. 2014;39(5):527–34.CrossRefPubMed
36.
Zurück zum Zitat Planas LG, Crosby KM, Mitchell KD, et al Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc (2003). 2009;49(2):164 – 70. Planas LG, Crosby KM, Mitchell KD, et al Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc (2003). 2009;49(2):164 – 70.
Metadaten
Titel
The first nationwide implementation of pharmaceutical care practices through a continuing professional development approach for community pharmacists
verfasst von
Sule Apikoglu
Aysu Selcuk
Vildan Ozcan
Ecehan Balta
Meltem Turker
Ozge Durak Albayrak
Arijana Mestrovic
Michael Rouse
Arman Uney
Publikationsdatum
14.06.2022
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 6/2022
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-022-01413-8

Weitere Artikel der Ausgabe 6/2022

International Journal of Clinical Pharmacy 6/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.